Navigation Links
New medicine for ovarian cancer

A medication called RAD001 may be the next drug that can stop the growth and spread of ovarian cancer cells.// The new medication targets an enzyme known as mammalian target of rapamycin (mTOR). The drug stopped the cells so that they cannot divide anymore or move o a different location and spread the cancer. The drug also reduces the cells ability to get nourishment from the blood vessels by a process called angiogenesis.

The new drug is a derivative of an immuno-suppressant drug called rapamycin.

Cancer in humans includes a high level of activity of an enzyme called AKT. This enzyme controls the cell activities, cell divisions and how the cell will respond to chemotherapy. AKT pathway remains highly active for a lot of different types of cancer, and yet does some functions healthy for the body as well. That was one of the reasons that the scientists did not target the enzyme AKT but a new enzyme.

The researchers of the Fox Chase Cancer Center in Philadelphia did the research and the study was presented at the 96th Annual Meeting of the American Association for Cancer Research (AACR).
'"/>




Page: 1

Related medicine news :

1. Alternative medicine more popular among HIV positive patients
2. Complementary and Alternative medicine
3. Pharmacies in for a dose of bitter medicine
4. Magnetic resonance angiography in clinical medicine
5. Approaching through Telemedicine benefits patients
6. Spreading knowledge to doctors about herbal medicine
7. Diuretics are better for treating blood pressure problems than newer medicines
8. Delay medicine for early epilepsy, says scientists
9. New dosage of medicine gets more results in neuroblastoma
10. Folk medicine is given more to UTI patients
11. Prohibited diet medicine found in Chinese herbs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... Franklin, TN (PRWEB) , ... May 26, 2016 , ... ... today, and more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, ... the 29th annual National Cancer Survivors Day®. , National Cancer Survivors Day® is ...
(Date:5/26/2016)... ... May 26, 2016 , ... In an effort to provide hair restoration information to the ... users and those who do not use the app. Dr. Mohebi, the founder of Parsa ... Dr. Mohebi Live . , Dr. Mohebi says, “The positive response to the Snapchat ...
(Date:5/26/2016)... Texas (PRWEB) , ... May 26, 2016 , ... ... Friday, May 13 at Blackhorse Golf Club in Cypress. With the help of community ... non-profit that restores, empowers, and renews hope for wounded service members and their families ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading ... PowerWave Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power ... the 8 hour interactive course to qualify participants as certified PowerWave trainers. ...
(Date:5/26/2016)... ... May 26, 2016 , ... The introduction of our ... PROTECTION TO YOUR HEAD ™”. , “We are proud to introduce Meghan ... football front we have Brian Quick, wide receiver for Los Angeles who was a ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 MedDay, a biotechnology ... that an oral presentation entitled "High doses of biotin in ... will be given by Professor Ayman Tourbah , Principal ... of the European Academy of Neurology (EAN) in ... disorders 3" will take place on Sunday, 29 May 2016 ...
(Date:5/24/2016)...   , ... primären Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung ... plus guter , Reinigung des ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... von der MORA-Studie der Phase III für NER1006 ...
(Date:5/24/2016)... , May 24, 2016 Celsion Corporation ... development company, today provided an update on its ... clinical trial combining GEN-1, the Company,s DNA-based immunotherapy, ... of newly-diagnosed patients with advanced ovarian cancer who ... surgery.  GEN-1 is an IL-12 DNA plasmid vector ...
Breaking Medicine Technology: